Abstract:BACKGROUND: Bone morphogenetic proteins (BMPs) are a group of cancer-related proteins vital for development and progression of certain cancer types. Nevertheless, function of BMP family in pan-cancer was not detailedly researched. OBJECTIVE: Investigating expression pattern and prognostic value of the BMPs family (BMP1-8A and BMP8B) expression across multiple cancer types. METHODS: Our research integrated multi-omics data for exploring potential associations between BMPs expression and prognosis, clinicopathological characteristics, copy number or somatic mutations, immune characteristics, tumor microenvironment (TME), tumor mutation burden (TMB), microsatellite instability (MSI), immune checkpoint genes and drug sensitivity in The Cancer Genome Atlas (TCGA) tumors. Furthermore, association of BMPs expression and immunotherapy effectiveness was investigated in some confirmatory cohorts (GSE111636, GSE78220, GSE67501, GSE176307, IMvigor210 and mRNA sequencing data from currently undergoing TRUCE01 clinical research included), and biological function and potential signaling pathways of BMPs in bladder cancer (BCa) was explored via Gene Set Enrichment Analysis (GSEA). Eventually, immune infiltration analysis was done via BMPs expression, copy number or somatic mutations in BCa, as well as validation of the expression levels by reverse transcription-quantitative PCR and western blot, and in vitro functional experiments of BMP8A. RESULTS: Discoveries displayed BMPs expression was related to prognosis, clinicopathological characteristics, mutations, TME, TMB, MSI and immune checkpoint genes of TCGA tumors. Anticancer drug sensitivity analysis displayed BMPs were associated with various drug sensitivities. What's more, it was discovered that expression level of certain BMP family members related to objective response to immunotherapy. By GSEA, we discovered multiple immune-associated functions and pathways were enriched. Immune infiltration analysis on BCa also displayed significant associations among BMPs copy number variations, mutation status and infiltration level of diverse immune cells. Furthermore, differential expression validation and in vitro phenotypic experiment indicated that BMP8A significantly promoted BCa cell proliferation, migration and invasion. CONCLUSIONS: Current results confirmed significance of both BMPs expression and genomic alteration in the prognosis and treatment of diverse cancer types, and suggested that BMPs may be vital for BCa and can possibly be utilized as biomarkers for immunotherapy.

Overexpression of BMP1 Reflects Poor Prognosis in Clear Cell Renal Cell Carcinoma

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

Bone morphogenetic protein 1: a prognostic indicator and potential biomarker in three cancer types

The prognostic significance and immune characteristics of bone morphogenetic proteins (BMPs) family: A pan-cancer multi-omics analysis

MP23-19 EZH2 CONTRIBUTES TO PROLIFERATION AND METASTASIS IN RENAL CELL CARCINOMA CELLS

Deregulated Bone Morphogenetic Proteins and Their Receptors Are Associated with Disease Progression of Gastric Cancer.

Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients

RUNX1 Predicts Poor Prognosis and Correlates with Tumor Progression in Clear Cell Renal Carcinoma

Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients

Downregulation of Guanine Nucleotide-Binding Protein Beta 1 (GNB1) is Associated with Worsened Prognosis of Clearcell Renal Cell Carcinoma and is Related to VEGF Signaling Pathway.

Integration of basement membrane-related genes in a risk signature for prognosis in clear cell renal cell carcinoma

Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma—a bioinformatics analysis

Aberrant Expression of Bone Morphogenetic Proteins in the Disease Progression and Metastasis of Breast Cancer

Loss of BAP1 Results in Growth Inhibition and Enhances Mesenchymal-Epithelial Transition in Kidney Tumor Cells.

High Jagged1 Expression Predicts Poor Outcome in Clear Cell Renal Cell Carcinoma

An Analysis of BMP1 Associated with m6A Modification and Immune Infiltration in Pancancer

Transcriptome Analyses Identify an RNA Binding Protein Related Prognostic Model for Clear Cell Renal Cell Carcinoma

CXCR1 Expression Predicts Benefit from Tyrosine Kinase Inhibitors Therapy in Patients with Metastatic Renal Cell Carcinoma

ZBP1 as a prognostic biomarker correlated with cell proliferation in clear cell renal cell carcinoma

The Prognostic Value of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma

Increased Expression of Forkhead Box M1 Protein is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma